Journal article Open Access

AN OVERVIEW ON NEWER ANTIDIABETIC AGENTS

Maliha Nishath, Amber Azeem, Sai Veena, Kadarla Rohith Kumar*

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action. Different classes of diabetes mellitus type1, type2 ,gestational is summarized. It is predicted that the prevalence of DM in adults of which type2 is becoming prominent mostly in developing countries. The treatment strategies are listed and many new drugs are currently in development for treatment of diabetes including more products with new mechanisms .Drugs with application submitted for US food and Drug administration (FDA) approval and drugs currently in phase3 clinical trials are summarized.

Files (654.2 kB)
Name Size
190813.pdf
md5:e7a14b8d8d55b463b03287476f9c6208
654.2 kB Download
5
28
views
downloads
All versions This version
Views 55
Downloads 2828
Data volume 18.3 MB18.3 MB
Unique views 55
Unique downloads 2626

Share

Cite as